CDKL5: Understanding rare epilepsies, patient by patient, neuron by neuron
Nine-year-old Haley Hilt has had intractable seizures all her life. Though she cannot speak, she communicates volumes with her eyes. Using a tablet she controls with her gaze, she can tell her parents when her head hurts and has shown that she knows her letters, numbers and shapes. Haley is one of a growing group...
The post CDKL5: Understanding rare epilepsies, patient by patient, neuron by neuron appeared first on Vector.
Deconstructed ‘death receptors’ suggest new ways to tackle cancer, autoimmune disease
Programmed cell death, or apoptosis, helps keep us healthy by ensuring that excess or potentially dangerous cells self-destruct. One way cells know it’s time to die is through signals received by so-called death receptors that stud cells’ surfaces. When these signals go awry, the result can be cancer (uncontrolled cell growth) or autoimmune disease (cells...
The post Deconstructed ‘death receptors’ suggest new ways to tackle cancer, autoimmune disease appeared first on Vector.
Who We are
The mission of the Technology and Innovation Development Office (TIDO) is to translate the excellence of the laboratory research and clinical care at Boston Children’s Hospital into lifesaving biomedical products, devices and procedures for the public benefit.
News and Events
Boston Children’s Technology Development Fund launches 2016 funding cycle
Letters of Intent are due to Technology Development Fund by emailing firstname.lastname@example.org on Feb. 8, 2016. More inside!
Updated Material Transfer Agreement (MTA) Procedures (Click here)
The new IP Policy allows for researchers to independently generate and complete certain outbound academic MTAs if specific criteria are met. In addition, we have implemented a new form for initiating inbound MTAs. Please click the link above for instructions and to download the forms.
New FAQ on Academic-Industry Partnerships
As part of our “Establishing Academic/Industry Partnerships” panel event held on May 5, TIDO produced an FAQ on academic-industry partnerships that explains the spectrum of relationships, the benefits of working with indsutry and how these relationships develop.